Oral glucose administration also causes rises in LEAP2 levels and the LEAP2/acyl-ghrelin molar ratio while type 1 diabetes mellitus (T1DM) causes rises in LEAP2 levels without changes in the LEAP2/ghrelin ratio. This evidence concerns the gene GHRL and type 1 diabetes mellitus.